<sub id="5szf3"></sub><form id="5szf3"><pre id="5szf3"><video id="5szf3"></video></pre></form>
    <tr id="5szf3"></tr>
    <strike id="5szf3"><p id="5szf3"></p></strike>

        <em id="5szf3"></em>

        Maternal and Child Health Testing

        PRODUCT

        25-OH-D3

        25 hydroxyvitamin D3

        25-OH-D3

        25 hydroxyvitamin D3

        【Name】
        25-hydroxyvitamin D3 (25-oh-d3) detection card (fluorescence immunochromatography)

        【Packing Specification】
        10 / box, 20 / box, 50 / box

        【Registration Certificate No. of Medical Device / Technical Requirement No. of Product】
        京械注準20152400845

        【Sample Requirements】
        No special treatment is needed for the patient's specimen. The whole blood specimen is collected by conventional medical technology, or the serum or plasma is drawn after centrifugation for immediate detection

        【Storage Conditions】
        The product is stored at 10 ℃ ~ 30 ℃

        【Validity】
        12 months

        VIEW

        This test card is used for quantitative determination of 25 hydroxyvitamin D3 in human serum, plasma or whole blood in vitro. The two most important forms of vitamin D are vitamin D3 (cholecalciferol) and vitamin D2 (ergot calciferol). In human body, vitamin D3 and D2 combine with vitamin D binding protein in plasma and transport to liver. They become 25 hydroxyvitamin d after 25 hydroxylation. More than 95% of 25 hydroxyvitamin D detected in serum is 25 hydroxyvitamin D3. Vitamin D deficiency is a common cause of secondary hyperparathyroidism. Increasing the content of parathyroid hormone, especially in the elderly without vitamin D, will lead to osteomalacia, increase bone turnover, reduce bone quality, and have the risk of fracture. The low content of 25 hydroxyvitamin D3 is also related to the low bone mineral density. Combined with other clinical data, the results can be used as an auxiliary means to determine bone metabolism.

        新讯网游戏